Increasing the Feasibility, Impact, and Equity of the Medicare Annual Wellness Visit (AWV)

NCT05910736 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 22485

Last updated 2026-05-08

No results posted yet for this study

Summary

The goal of this study is to improve the use of preventive health services by implementing a multilevel intervention to stimulate Annual Wellness Visit use in diverse practices across the United States. This is a stepped wedge cluster randomized controlled trial. The intervention will be implemented in a total of 24 primary care practices over 24 months. Every 3 months, 6 practices will receive the intervention. Electronic health record (EHR) data extractions will be used to collect outcomes in a population cohort of patients. Semi-structured interviews will be conducted with clinicians/staff and patients to assess intervention implementation. The investigators hypothesize that the implementation will increase AWV visit use and consequently, use of preventive health services.

Conditions

  • Preventive Health Services

Interventions

BEHAVIORAL

Medicare AWV Practice Redesign Toolkit

Electronic health record-based tools coupled with practice redesign strategies and approaches

Sponsors & Collaborators

  • DARTNet

    collaborator UNKNOWN
  • American Academy of Family Physicians National Research Network

    collaborator NETWORK
  • Case Western Reserve University

    collaborator OTHER
  • MetroHealth System, Ohio

    collaborator OTHER
  • University of California, Los Angeles

    lead OTHER

Principal Investigators

  • Derjung M Tarn, MD, PhD · University of California, Los Angeles

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-01
Primary Completion
2027-08-31
Completion
2028-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05910736 on ClinicalTrials.gov